BlueWillow Biologics

Quick facts

Phase 1 pipeline

• BW-1010: 100 µg - pipette - IN
• BW-1010: 100 µg - sprayer - IN
• BW-1010: 50 µg - pipette - IN
• BW-1010: 50 µg - sprayer - IN
• BW-1014: 100 µg rH5 in 20% NE - pipette - IN
• BW-1014: 50 µg rH5 in 20% NE - pipette - IN
• H5N1 IIV - IM

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BlueWillow Biologics portfolio CI brief
• BlueWillow Biologics pipeline updates RSS